MAT Clinic Marketing

MAT clinic marketing now the waiver is gone and the competition is not.

Since Congress killed the X-waiver, every DEA-registered prescriber can treat opioid use disorder. Primary care came in, telehealth came in, and the clinics that owned these searches for a decade now share them.

The short answer

MAT clinic marketing brings patients to programs prescribing buprenorphine, methadone, or naltrexone for opioid use disorder. Two facts shape it. Congress eliminated the DATA-Waiver in the Consolidated Appropriations Act of 2023, so any DEA-registered prescriber with Schedule III authority can prescribe buprenorphine, and the field got crowded fast. And 42 CFR Part 2 governs substance use records more tightly than HIPAA, which limits what call recordings, forms, and retargeting audiences may contain. Medicaid is the dominant payer, so acquisition cost is judged against months of retained visits.

new MAT patients per month across clients — verify with Tim

New patients produced monthly

typical 90-day retention on marketing-sourced patients — verify

Ninety-day retention on marketing-sourced patients

Every prescriber is a competitor now

Before 2023, prescribing buprenorphine required the DATA-Waiver, and the list of waivered prescribers in a county was short enough to memorize. Congress removed that requirement and the constraint on supply went with it. Family medicine practices added it. Urgent cares added it. Telehealth companies with national ad budgets added it everywhere at once.

Demand did not grow at the same rate. So a clinic that used to rank by default now competes against practices with no addiction specialty at all and a faster intake.

The advantage a real MAT program still holds is depth: counseling, case management, same-day starts, on-site dosing, wraparound services. None of it is visible in a search result until somebody writes it down on the page.

Medicaid economics change what a patient is worth

A residential program can spend thousands to acquire one admission because the episode bills at tens of thousands. A MAT clinic billing Medicaid for an office visit and a monthly prescription cannot. On a per-visit basis the numbers do not work.

They work over time. A retained MAT patient comes back every week, then every two weeks, then monthly, for months or years. The value is in retention, so acquisition has to be measured at day 30 and day 90 rather than at the first appointment.

This is where most MAT reporting falls apart. The agency reports new patient calls. Nobody reports how many of those patients came back a second time. A channel producing cheap first visits and 20% thirty-day retention costs more than one producing expensive first visits that stick.

MAT Clinic Marketing: how we run it for medication-assisted treatment clinics

01

Local search per prescribing site

Suboxone doctor near me, MAT clinic near me, opioid treatment near a city name. These resolve on proximity, profile completeness, and reviews. Every location gets its own profile, its own page, and its own review stream instead of pointing at a corporate address.

02

Insurance and cash-price pages

Whether Medicaid covers treatment in a given state is one of the highest-volume questions in this category, and almost nobody answers it plainly. We publish the accepted plans, the cash price, and what the first visit costs. It ranks and it converts, because the people searching are deciding whether they can afford to call.

03

Paid search under certification

LegitScript certification first. Then generic clinical phrasing over brand-name drug terms in the ad copy, landing pages that match the query, and geo-targeting tight enough that you stop paying for clicks two hours away.

04

Intake speed measured, not assumed

We instrument time from first call to first appointment. A clinic that books within 24 hours converts a different fraction of its calls than one offering next Thursday. When that gap is the constraint, more traffic will not fix it, and we will say so.

05

A Part 2-safe tracking stack

Call tracking, forms, analytics, and CRM configured so treatment-seeking behavior never reaches an ad platform. Most setups we inherit fire a conversion pixel on a page whose URL names the condition. That gets fixed in week one.

Free audit

Want to see where your calls are going?

We audit your rankings, ads, and call tracking against the programs you compete with, then show you what is leaking. Yours to keep either way.

Prefer the phone? (561) 269-2833

Compliance

The rules that apply to this category

This is the part that catches agencies who have not worked in this category before.

42 CFR Part 2 is stricter than HIPAA

Records identifying someone as a substance use disorder patient of a Part 2 program carry consent requirements HIPAA does not impose. That reaches your intake call recordings, form submissions, chat transcripts, CRM notes, and any audience list built from them. Third-party pixels on treatment pages are the most common violation we find.

LegitScript certification and drug names in ad copy

Google requires addiction treatment certification before your ads run. Separately, ad copy built around brand-name medications draws policy review far more often than copy describing the service. We write to the clinical service and let the drug names live on the landing page.

Telehealth prescribing rules keep moving

DEA flexibilities for prescribing controlled substances by telemedicine have been extended repeatedly since 2020, and each extension carries its own end date. Do not build an intake funnel or an ad campaign around telehealth starts without checking the rule in force that month. current DEA telemedicine flexibility expiration date — check before launch

EKRA and per-patient marketing fees

The Eliminating Kickbacks in Recovery Act covers clinical treatment facilities and prohibits paying for patient referrals. Marketing priced per patient acquired, or as a percentage of what those patients bill, is federal exposure. Flat fees for work performed are the safe structure.

FAQ

Questions we get asked

Is MAT marketing different from rehab marketing?

The compliance overlaps and the economics do not. Rehab sells a high-ticket episode and can afford an expensive admission. A MAT clinic sells recurring outpatient visits, often at Medicaid rates, so acquisition cost has to be small and retention has to be measured. The search behavior differs too: MAT queries are local, urgent, and price-sensitive.

Can we advertise Suboxone by name?

On your website, yes. Ad copy is where it gets difficult, because Google reviews prescription drug terms more aggressively and disapprovals slow every launch. We run the ads on the service and put the medication detail on the landing page.

What does 42 CFR Part 2 change about our website?

Anything recording a person as seeking substance use treatment becomes a protected record. In practice: no advertising pixels firing on treatment pages, no call recordings pushed into ad platforms, no remarketing audiences built from treatment-page visits, and a consent flow on your forms. It is a configuration problem with a real answer, not a reason to stop measuring.

How long until we see new patients?

Local search fixes on a Google Business Profile can move calls within weeks, because these are near-me searches with little content behind them. Organic on state and city terms takes three to six months. Paid search starts producing as soon as certification clears.

Do you work with telehealth-only MAT providers?

Yes, and the playbook is different. You compete nationally against funded companies, licensure limits which states you can appear in at all, and acquisition costs more because there is no local pack to win. We will tell you whether your state footprint is large enough for the math to work.

What should we measure?

Cost per new patient, first-appointment show rate, and retention at 30 and 90 days, each split by channel. Rankings and impressions tell you nothing about whether the clinic filled its schedule.

Free audit

Find out where your calls are leaking.

We take apart your rankings, your ads, and your call tracking, then show you where the calls are going instead of to you. The audit is yours to keep whether we work together or not.

Prefer the phone? (561) 269-2833